Literature DB >> 33716480

A Case Series of Catheter-Directed Thrombolysis With Mechanical Thrombectomy for Treating Severe Deep Vein Thrombosis.

Eric Kwoh1, Jonathan M Helali1, Casey Kaneshiro1, Jaime Betancourt1.   

Abstract

Two cases of extensive symptomatic deep vein thrombosis without phlegmasia cerulea dolens were successfully treated with an endovascular technique that combines catheter-directed thrombolysis and mechanical thrombectomy.
Copyright © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2021        PMID： 33716480      PMCID： PMC7953858          DOI： 10.12788/fp.0085

Source DB:  PubMed          Journal:  Fed Pract        ISSN： 1078-4497


  12 in total

1.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Phlegmasia cerulea dolens.

Authors:  Salman Sarwar; Srilakshmi Narra; Ahmad Munir
Journal:  Tex Heart Inst J       Date:  2009

3.  Comparative outcomes of catheter-directed thrombolysis plus anticoagulation vs anticoagulation alone to treat lower-extremity proximal deep vein thrombosis.

Authors:  Riyaz Bashir; Chad J Zack; Huaqing Zhao; Anthony J Comerota; Alfred A Bove
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

Review 4.  Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis.

Authors:  Lindsay Robertson; Olivia McBride; Anne Burdess
Journal:  Cochrane Database Syst Rev       Date:  2016-11-04

5.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Authors:  Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores
Journal:  Chest       Date:  2016-01-07       Impact factor: 9.410

Review 6.  Thrombolysis for acute deep vein thrombosis.

Authors:  Lorna Watson; Cathryn Broderick; Matthew P Armon
Journal:  Cochrane Database Syst Rev       Date:  2016-11-10

7.  Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.

Authors:  Tone Enden; Ylva Haig; Nils-Einar Kløw; Carl-Erik Slagsvold; Leiv Sandvik; Waleed Ghanima; Geir Hafsahl; Pål Andre Holme; Lars Olaf Holmen; Anne Mette Njaastad; Gunnar Sandbæk; Per Morten Sandset
Journal:  Lancet       Date:  2011-12-13       Impact factor: 79.321

Review 8.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

9.  Determinants of health-related quality of life during the 2 years following deep vein thrombosis.

Authors:  S R Kahn; H Shbaklo; D L Lamping; C A Holcroft; I Shrier; M J Miron; A Roussin; S Desmarais; F Joyal; J Kassis; S Solymoss; L Desjardins; M Johri; J S Ginsberg
Journal:  J Thromb Haemost       Date:  2008-06-01       Impact factor: 5.824

10.  Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.

Authors:  Suresh Vedantham; Samuel Z Goldhaber; Jim A Julian; Susan R Kahn; Michael R Jaff; David J Cohen; Elizabeth Magnuson; Mahmood K Razavi; Anthony J Comerota; Heather L Gornik; Timothy P Murphy; Lawrence Lewis; James R Duncan; Patricia Nieters; Mary C Derfler; Marc Filion; Chu-Shu Gu; Stephen Kee; Joseph Schneider; Nael Saad; Morey Blinder; Stephan Moll; David Sacks; Judith Lin; John Rundback; Mark Garcia; Rahul Razdan; Eric VanderWoude; Vasco Marques; Clive Kearon
Journal:  N Engl J Med       Date:  2017-12-07       Impact factor: 176.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.